D. E. Shaw & Co., Inc. Cellectis S.A. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.58 - $2.86 $50,046 - $90,590	-31,675 Reduced 40.18%	47,154 $74,000
Q2 2023 Aug 14, 2023	SELL	$1.72 - $2.12 $75,165 - $92,646	-43,701 Reduced 35.67%	78,829 $155,000
Q1 2023 May 15, 2023	SELL	$1.83 - $3.84 $191,385 - $401,594	-104,582 Reduced 46.05%	122,530 $236,000
Q4 2022 Feb 14, 2023	SELL	$1.85 - $2.6 $94,747 - $133,159	-51,215 Reduced 18.4%	227,112 $476,000
Q3 2022 Nov 14, 2022	BUY	$2.29 - $4.08 $15,521 - $27,654	6,778 Added 2.5%	278,327 $637,000
Q2 2022 Aug 15, 2022	SELL	$2.39 - $4.93 $67,249 - $138,720	-28,138 Reduced 9.39%	271,549 $768,000
Q1 2022 May 16, 2022	BUY	$3.45 - $8.77 $375,166 - $953,684	108,744 Added 56.95%	299,687 $1.36 Million
Q4 2021 Feb 14, 2022	BUY	$8.01 - $12.84 $820,392 - $1.32 Million	102,421 Added 115.7%	190,943 $1.55 Million
Q3 2021 Nov 15, 2021	SELL	$11.94 - $16.09 $80,559 - $108,559	-6,747 Reduced 7.08%	88,522 $1.12 Million
Q2 2021 Aug 16, 2021	SELL	$14.36 - $20.93 $49,269 - $71,810	-3,431 Reduced 3.48%	95,269 $1.47 Million
Q1 2021 May 17, 2021	SELL	$18.19 - $33.25 $363,272 - $664,035	-19,971 Reduced 16.83%	98,700 $2 Million
Q4 2020 Feb 16, 2021	BUY	$15.87 - $31.64 $25,550 - $50,940	1,610 Added 1.38%	118,671 $3.21 Million
Q3 2020 Nov 16, 2020	SELL	$15.7 - $20.84 $1.38 Million - $1.84 Million	-88,084 Reduced 42.94%	117,061 $2.17 Million
Q2 2020 Aug 14, 2020	BUY	$8.21 - $21.02 $656,217 - $1.68 Million	79,929 Added 63.83%	205,145 $3.65 Million
Q1 2020 May 15, 2020	SELL	$7.81 - $18.82 $524,160 - $1.26 Million	-67,114 Reduced 34.9%	125,216 $1.15 Million
Q4 2019 Feb 14, 2020	BUY	$9.73 - $19.31 $536,191 - $1.06 Million	55,107 Added 40.16%	192,330 $3.29 Million
Q3 2019 Nov 14, 2019	BUY	$10.15 - $16.89 $1.07 Million - $1.77 Million	105,023 Added 326.16%	137,223 $1.43 Million
Q2 2019 Aug 14, 2019	BUY	$14.6 - $20.6 $470,120 - $663,320	32,200 New	32,200 $502,000
Q2 2018 Aug 14, 2018	SELL	$27.78 - $38.53 $991,884 - $1.38 Million	-35,705 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$27.78 - $35.19 $991,884 - $1.26 Million	35,705 New	35,705 $1.13 Million

Others Institutions Holding CLLS

# of Institutions

Shares Held

11.2M

Call Options Held

2.8K

Put Options Held

17.9K

Long Focus Capital Management, LLC San Juan, PR

4.62M
Shares

$8.4 Million
0.35% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$3.36 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.62 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

1.44M
Shares

$2.62 Million
0.0% of portfolio
Baillie Gifford & CO

708K
Shares

$1.29 Million
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $82.8M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account